Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 4/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 4/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18793782 | 1.00 | ADRA2A (0.42) | ADRA2AADRA2BADRA2CADRA1AADRA1B | |
| SCHEMBL13159672 | 1.00 | ADRA2A (0.42) | ADRA2AADRA2BADRA2CADRA1AADRA1B | |
| SCHEMBL17963769 | 0.84 | ADRA2A (0.40) | ADRA2AADRA2BADRA2CADRA1AADRA1B | |
| SCHEMBL593086 | 0.83 | ESR1 (0.46) | TSHRCYP1A2GABRA1GABRG2GABRB3 | |
| SCHEMBL27391011 | 0.81 | TSHR (0.52) | ADRA2AADRA2BADRA2CADRA1AADRA1B | |
| SCHEMBL20738578 | 0.80 | GABRA1 (0.39) | ADRA2AADRA2BADRA2CTSHRCYP1A2 | |
| SCHEMBL9558664 | 0.79 | ADRA2A (0.42) | ADRA2AADRA2BADRA2CADRA1AADRA1B | |
| SCHEMBL25303539 | 0.79 | ADRA2A (0.39) | ADRA2AADRA2BADRA2CADRA1AADRA1B | |
| SCHEMBL16952251 | 0.78 | TRPA1 (0.40) | ADRA2AADRA2BADRA2CADRA1AADRA1B | |
| SCHEMBL29337470 | 0.78 | TRPA1 (0.40) | ADRA2AADRA2BADRA2CADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111217756-A | Preparation method of dexmedetomidine hydrochloride | 南京亿华药业有限公司 | 2020-06-02 | — | — | CN | claimed |
| EP-3006547-B1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO CO LTD (JP) | 2019-10-30 | — | — | EP | claimed |
| EP-3349861-A1 | PERFUME COMPOSITION COMPRISING FRAGRANCE MODULATOR COMPOUNDS AND SILICIC ACID ESTERS FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE | Henkel AG & Co. KGaA (DE) | 2018-07-25 | — | — | EP | claimed |
| WO-2017046052-A1 | PERFUME COMPOSITION COMPRISING FRAGRANCE MODULATOR COMPOUNDS AND SILICIC ACID ESTERS FOR INCREASING AND PROLONGING THE INTENSITY OF FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2017-03-23 | — | — | WO | claimed |
| US-20140357547-A1 | PROCESS FOR THE PREPARATION OF METHOXYMELONAL | GIVAUDAN S.A. (CH) | 2014-12-04 | — | — | US | claimed |
| EP-2766333-A1 | PROCESS FOR THE PREPARATION OF METHOXYMELONAL | Givaudan SA (CH) | 2014-08-20 | — | — | EP | claimed |
| WO-2013053787-A1 | PROCESS FOR THE PREPARATION OF METHOXYMELONAL | GIVAUDAN SA (CH) | 2013-04-18 | — | — | WO | claimed |
| EP-2248866-B1 | FUNCTIONAL MATERIAL RELEASE AGENT | KAO CORP (JP) | 2013-04-03 | — | — | EP | claimed |
| EP-2251392-B1 | AGENT FOR RELEASING FUNCTIONAL SUBSTANCE | KAO CORP (JP) | 2013-02-27 | — | — | EP | claimed |
| US-20130017990-A1 | LILIAL SURROGATE | HENKEL AG & CO., KGAA (DE) | 2013-01-17 | — | — | US | claimed |
| EP-2408885-A1 | LILIAL SURROGATE | Henkel AG & Co. KGaA (DE) | 2012-01-25 | — | — | EP | claimed |
| WO-2010105874-A1 | LILIAL SURROGATE | HENKEL AG & CO. KGAA (DE) | 2010-09-23 | — | — | WO | claimed |
| WO-2010105873-A2 | LILIAL SUBSTITUTE | HENKEL AG & CO. KGAA (DE) | 2010-09-23 | — | — | WO | claimed |
| EP-1099689-B1 | Functional alcohol releasing substance | KAO CORP (JP) | 2005-08-03 | — | — | EP | claimed |
| EP-0622451-B1 | Perfumed hypochlorite bleaching compositions | PROCTER & GAMBLE (US) | 1998-12-02 | — | — | EP | claimed |
| EP-3218459-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-09-03 | — | — | EP | disclosed |
| EP-3689849-B1 | PERFUME PRECURSOR | TAKASAGO PERFUMERY CO LTD (JP) | 2025-01-15 | — | — | EP | disclosed |
| WO-1983000697-A1 | POLYESTER COMPOSITION | ETHYL CORP (US) | 1983-03-03 | — | — | WO | disclosed |
| EP-0073042-A1 | Polyester composition | ETHYL CORPORATION (US) | 1983-03-02 | — | — | EP | disclosed |
| US-4368145-A | ALCOHOL ESTERS AND ALDEHYDE ESTERS | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 1983-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357547-A1 | PROCESS FOR THE PREPARATION OF METHOXYMELONAL | MSMO1, CYP17A1, CYP51A1 | ADRA2A 506/4885ADRA2B 481/4885ADRA2C 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.